High and low responsiveness in renal transplantation and its impact on HLA matching

  • J. J. van Rood
  • G. F. J. Hendriks
Part of the Developments in Surgery book series (DISU, volume 5)


The question whether or not HLA matching can modify the amount of immunosuppressive drugs needed for good graft survival can, of course, be answered in the affirmative. It is a well established fact that grafts exchanged between HLA-identical sibling donor-recipient combinations require less immunosuppression and survive better than grafts exchanged between mismatched living related combinations, and, of course, than grafts obtained from cadaveric donors.


Graft Survival Renal Allograft High Responder Improve Graft Survival Mismatched Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Van Rood JJ: Pretransplant blood transfusion. Sure but how and why! Transpl Proc XV: 915–916, 1983.Google Scholar
  2. 2.
    Diamondopoulos AA, Hamilton DNH, Briggs JD: A new predictive factor for the outcome of renal transplantation. In: Proceedings EDTA Congress, Robinson BHB, Hawkins JB (eds). Tunbridge Wells UK, Pitman Med Publ Co Ltd 1978 (vol 15) pp 283–288.Google Scholar
  3. 3.
    Lehner T: The relationship between human helper and suppressor factors to a streptococcal protein antigen. J Immunol 129: 1936–1940, 1982.PubMedGoogle Scholar
  4. 4.
    Baldwin FHJ, Claas EHJ, Van Es LA, Van Rood JJ, Paul LC, Persijn GG: Renal graft rejection and the antigenic anatomy of human kidneys. In: Transpl Clin Immunol (Touraine JL et al (eds). Amsterdam, Excerpta Medica, 1981 (vol XIII) pp 140–146.Google Scholar
  5. 5.
    Hendriks GFJ, Claas FHJ, Persijn GG, Witvliet MD, Baldwin W, van Rood JJ: HLA-DRw6-positive recipients are high responders in renal transplantation. Transpl Proc 15: 1136–1138, 1983.Google Scholar
  6. 6.
    Soulillou JP, Bignon JD: Poor kidney-graft survival in recipients with HLA-DRw6. N Engl J Med 308: 969–970, 1983.PubMedGoogle Scholar
  7. 7.
    Hendriks GFJ, D&x2019;Amaro J, Persijn GG, Schreuder GMTh, Lansbergen O, Cohen B, Van Rood JJ: Excellent renal allograft prognosis with DRw6 positive donors in the face of HLA-DR mismatches. The Lancet (In press) 1983.Google Scholar
  8. 8.
    Hendriks GFL, Schreuder GMTh, Claas FHJ, D&x2019;Amaro J, Persijn GG, Cohen B, Van Rood JJ: HLA-DRw6 and renal allograft rejection. Brit Med J 286: 85–87, 1983.CrossRefGoogle Scholar
  9. 9.
    Woodruff M, Van Rood JJ: Possible implications of the effect of blood transfusion on allograft survival. The Lancet, May 28: 1201–1203, 1983.CrossRefGoogle Scholar
  10. 10.
    Hoitsma HJ, Reekers P, Van Lier HJJ, Van Rens JG, Koene RAP: HLA-DRw6 and treatment of acute rejection with anti-thymocyte globulin in renal transplantation. Brit Med J (Submitted).Google Scholar
  11. 11.
    Van Hooff JP, Van Es A, Persijn GG, Van Hooff-Eykenboom IJEA, Kalff MW, Van Rood JJ, De Graeff J: Cadaveric graft survival, clinical course, blood transfusions, HLA-(A and B) match, and-DR match in adult patients transplanted in one centre. In: Proceedings EDTA Congress (Robinson BHB, Hawkins JB, Naik RB (eds). Tunbridge Wells UK, Pitman Med Publ Co Ltd, 1979 (vol 16) pp 359–365.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1984

Authors and Affiliations

  • J. J. van Rood
  • G. F. J. Hendriks

There are no affiliations available

Personalised recommendations